Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Prospective development of a patient-reported outcomes instrument for desmoid tumors or aggressive fibromatosis.

Gounder MM, Maddux L, Paty J, Atkinson TM.

Cancer. 2019 Nov 6. doi: 10.1002/cncr.32555. [Epub ahead of print]

PMID:
31691276
2.

A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease.

Diamond EL, Reiner AS, Buthorn JJ, Shuk E, Applebaum AJ, Hyman DM, Abdel-Wahab O, Rampal R, Janku F, Brewer K, Campbell J, Mao JJ, Atkinson TM, Panageas KS.

Blood Adv. 2019 Apr 9;3(7):934-938. doi: 10.1182/bloodadvances.2018030502.

3.

Leveraging Latent Dirichlet Allocation in processing free-text personal goals among patients undergoing bladder cancer surgery.

Li Y, Rapkin B, Atkinson TM, Schofield E, Bochner BH.

Qual Life Res. 2019 Jun;28(6):1441-1455. doi: 10.1007/s11136-019-02132-w. Epub 2019 Feb 23.

4.

Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy.

Feuerstein MA, Goldstein L, Reaves B, Sun A, Goltzman M, Morganstern BA, Shabsigh A, Bajorin DF, Rosenberg JE, Donat SM, Herr HW, Laudone VP, Atkinson TM, Li Y, Dalbagni G, Rapkin B, Bochner BH.

World J Urol. 2019 Nov;37(11):2401-2407. doi: 10.1007/s00345-019-02692-z. Epub 2019 Feb 23.

5.

Lung cancer stigma and depression: Validation of the Lung Cancer Stigma Inventory.

Ostroff JS, Riley KE, Shen MJ, Atkinson TM, Williamson TJ, Hamann HA.

Psychooncology. 2019 May;28(5):1011-1017. doi: 10.1002/pon.5033. Epub 2019 Apr 16.

PMID:
30779396
6.

Perceptions of Response Burden Associated with Completion of Patient-Reported Outcome Assessments in Oncology.

Atkinson TM, Schwartz CE, Goldstein L, Garcia I, Storfer DF, Li Y, Zhang J, Bochner BH, Rapkin BD.

Value Health. 2019 Feb;22(2):225-230. doi: 10.1016/j.jval.2018.07.875. Epub 2018 Aug 31.

PMID:
30711068
7.

Reliability and between-group stability of a health-related quality of life symptom index for persons with anal high-grade squamous intraepithelial lesions: an AIDS Malignancy Consortium Study (AMC-A03).

Atkinson TM, Palefsky J, Li Y, Webb A, Berry JM, Goldstone S, Levine R, Wilkin TJ, Bucher G, Cella D, Burkhalter JE; ANCHOR HRQoL Implementation Group.

Qual Life Res. 2019 May;28(5):1265-1269. doi: 10.1007/s11136-018-2089-8. Epub 2019 Jan 7.

PMID:
30617704
8.

Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events.

Atkinson TM, Reeve BB, Dueck AC, Bennett AV, Mendoza TR, Rogak LJ, Basch E, Li Y.

J Patient Rep Outcomes. 2018 Dec 4;2(1):56. doi: 10.1186/s41687-018-0086-x.

9.

Initial Development and Content Validation of a Health-Related Symptom Index for Persons either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions.

Burkhalter JE, Atkinson TM, Berry-Lawhorn J, Goldstone S, Einstein MH, Wilkin TJ, Lee J, Cella D, Palefsky JM; ANCHOR HRQOL Implementation Group.

Value Health. 2018 Aug;21(8):984-992. doi: 10.1016/j.jval.2018.01.018. Epub 2018 Apr 11.

10.

Reply to E. Younger et al.

Atkinson TM, Gounder MM.

J Clin Oncol. 2018 Jun 1;36(16):1643-1644. doi: 10.1200/JCO.2018.78.0478. Epub 2018 Apr 18. No abstract available.

11.

What Do "None," "Mild," "Moderate," "Severe," and "Very Severe" Mean to Patients With Cancer? Content Validity of PRO-CTCAE™ Response Scales.

Atkinson TM, Hay JL, Dueck AC, Mitchell SA, Mendoza TR, Rogak LJ, Minasian LM, Basch E.

J Pain Symptom Manage. 2018 Mar;55(3):e3-e6. doi: 10.1016/j.jpainsymman.2017.10.024. Epub 2017 Nov 10. No abstract available.

12.

Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE.

Mendoza TR, Dueck AC, Bennett AV, Mitchell SA, Reeve BB, Atkinson TM, Li Y, Castro KM, Denicoff A, Rogak LJ, Piekarz RL, Cleeland CS, Sloan JA, Schrag D, Basch E.

Clin Trials. 2017 Jun;14(3):255-263. doi: 10.1177/1740774517698645. Epub 2017 Mar 20.

13.

Patient-Reported Physical Function Measures in Cancer Clinical Trials.

Atkinson TM, Stover AM, Storfer DF, Saracino RM, D'Agostino TA, Pergolizzi D, Matsoukas K, Li Y, Basch E.

Epidemiol Rev. 2017 Jan 1;39(1):59-70. doi: 10.1093/epirev/mxx008. Review.

14.

Promoting patient participation in healthcare interactions through communication skills training: A systematic review.

D'Agostino TA, Atkinson TM, Latella LE, Rogers M, Morrissey D, DeRosa AP, Parker PA.

Patient Educ Couns. 2017 Jul;100(7):1247-1257. doi: 10.1016/j.pec.2017.02.016. Epub 2017 Feb 16. Review.

15.

Cardiovascular and Ventilatory Consequences of Laparoscopic Surgery.

Atkinson TM, Giraud GD, Togioka BM, Jones DB, Cigarroa JE.

Circulation. 2017 Feb 14;135(7):700-710. doi: 10.1161/CIRCULATIONAHA.116.023262.

PMID:
28193800
16.

Platelets and von Willebrand factor in atherogenesis.

Wu MD, Atkinson TM, Lindner JR.

Blood. 2017 Mar 16;129(11):1415-1419. doi: 10.1182/blood-2016-07-692673. Epub 2017 Feb 7. Review.

17.

Exploring differences in adverse symptom event grading thresholds between clinicians and patients in the clinical trial setting.

Atkinson TM, Rogak LJ, Heon N, Ryan SJ, Shaw M, Stark LP, Bennett AV, Basch E, Li Y.

J Cancer Res Clin Oncol. 2017 Apr;143(4):735-743. doi: 10.1007/s00432-016-2335-9. Epub 2017 Jan 16.

18.

Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma.

Atkinson TM, Hay JL, Shoushtari A, Li Y, Paucar DJ, Smith SC, Kudchadkar RR, Doyle A, Sosman JA, Quevedo JF, Milhem MM, Joshua AM, Linette GP, Gajewski TF, Lutzky J, Lawson DH, Lao CD, Flynn PJ, Albertini MR, Sato T, Lewis K, Marr B, Abramson DH, Dickson MA, Schwartz GK, Carvajal RD.

J Cancer Res Clin Oncol. 2017 Mar;143(3):439-445. doi: 10.1007/s00432-016-2318-x. Epub 2016 Dec 5.

19.

Functional adaptations of the coronary microcirculation to anaemia in fetal sheep.

Jonker SS, Davis L, Soman D, Belcik JT, Davidson BP, Atkinson TM, Wilburn A, Louey S, Giraud GD, Lindner JR.

J Physiol. 2016 Nov 1;594(21):6165-6174. doi: 10.1113/JP272696. Epub 2016 Jul 18.

20.

Trustworthiness of Patient-Reported Outcomes in Unblinded Cancer Clinical Trials.

Atkinson TM, Wagner JS, Basch E.

JAMA Oncol. 2017 Jun 1;3(6):738-739. doi: 10.1001/jamaoncol.2016.3328. No abstract available.

21.

The Association Between Patient-Reported and Objective Oral Anticancer Medication Adherence Measures: A Systematic Review
.

Atkinson TM, Rodríguez VM, Gordon M, Avildsen IK, Emanu JC, Jewell ST, Anselmi KA, Ginex PK.

Oncol Nurs Forum. 2016 Sep 1;43(5):576-82. doi: 10.1188/16.ONF.576-582. Review.

22.

Reply: High-Risk Percutaneous Coronary Interventions: First, Do No Harm.

Atkinson TM, Ohman EM, O'Neill WW, Rab T, Cigarroa JE.

JACC Cardiovasc Interv. 2016 Aug 22;9(16):1753-4. doi: 10.1016/j.jcin.2016.06.039. No abstract available.

23.

The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review.

Atkinson TM, Ryan SJ, Bennett AV, Stover AM, Saracino RM, Rogak LJ, Jewell ST, Matsoukas K, Li Y, Basch E.

Support Care Cancer. 2016 Aug;24(8):3669-76. doi: 10.1007/s00520-016-3297-9. Epub 2016 Jun 3. Review.

24.

Examining the Association between Patient-Reported Symptoms of Attention and Memory Dysfunction with Objective Cognitive Performance: A Latent Regression Rasch Model Approach.

Li Y, Root JC, Atkinson TM, Ahles TA.

Arch Clin Neuropsychol. 2016 Jun;31(4):365-77. doi: 10.1093/arclin/acw017. Epub 2016 Apr 24.

25.

A Practical Approach to Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: An Interventional Perspective.

Atkinson TM, Ohman EM, O'Neill WW, Rab T, Cigarroa JE; Interventional Scientific Council of the American College of Cardiology.

JACC Cardiovasc Interv. 2016 May 9;9(9):871-83. doi: 10.1016/j.jcin.2016.02.046. Review.

26.

Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.

McCarrier KP, Atkinson TM, DeBusk KP, Liepa AM, Scanlon M, Coons SJ; Patient-Reported Outcome Consortium, Non–Small Cell Lung Cancer Working Group.

Clin Ther. 2016 Apr;38(4):794-810. doi: 10.1016/j.clinthera.2016.03.012. Epub 2016 Apr 1.

27.

Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood (AYA): a systematic review.

Barnett M, McDonnell G, DeRosa A, Schuler T, Philip E, Peterson L, Touza K, Jhanwar S, Atkinson TM, Ford JS.

J Cancer Surviv. 2016 Oct;10(5):814-31. doi: 10.1007/s11764-016-0527-6. Epub 2016 Feb 26. Review.

28.

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Bennett AV, Dueck AC, Mitchell SA, Mendoza TR, Reeve BB, Atkinson TM, Castro KM, Denicoff A, Rogak LJ, Harness JK, Bearden JD, Bryant D, Siegel RD, Schrag D, Basch E; National Cancer Institute PRO-CTCAE Study Group.

Health Qual Life Outcomes. 2016 Feb 19;14:24. doi: 10.1186/s12955-016-0426-6.

29.

Conflating Colorectal Cancer Screening and Diagnostic Testing-Letter.

Atkinson TM, Salz T, Hay JL.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):425. doi: 10.1158/1055-9965.EPI-15-1173. Epub 2015 Dec 8. No abstract available.

30.

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial.

Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D.

J Clin Oncol. 2016 Feb 20;34(6):557-65. doi: 10.1200/JCO.2015.63.0830. Epub 2015 Dec 7. Erratum in: J Clin Oncol. 2016 Jun 20;34(18):2198. Erratum in: J Clin Oncol. 2019 Feb 20;37(6):528.

31.

The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review.

Atkinson TM, Andreotti CF, Roberts KE, Saracino RM, Hernandez M, Basch E.

Support Care Cancer. 2015 Dec;23(12):3645-52. doi: 10.1007/s00520-015-2923-2. Epub 2015 Aug 28. Review.

32.

Does colorectal cancer risk perception predict screening behavior? A systematic review and meta-analysis.

Atkinson TM, Salz T, Touza KK, Li Y, Hay JL.

J Behav Med. 2015 Dec;38(6):837-50. doi: 10.1007/s10865-015-9668-8. Epub 2015 Aug 18. Review.

33.

Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Dueck AC, Mendoza TR, Mitchell SA, Reeve BB, Castro KM, Rogak LJ, Atkinson TM, Bennett AV, Denicoff AM, O'Mara AM, Li Y, Clauser SB, Bryant DM, Bearden JD 3rd, Gillis TA, Harness JK, Siegel RD, Paul DB, Cleeland CS, Schrag D, Sloan JA, Abernethy AP, Bruner DW, Minasian LM, Basch E; National Cancer Institute PRO-CTCAE Study Group.

JAMA Oncol. 2015 Nov;1(8):1051-9. doi: 10.1001/jamaoncol.2015.2639. Erratum in: JAMA Oncol. 2016 Jan;2(1):146.

34.

Reliable change in neuropsychological assessment of breast cancer survivors.

Andreotti C, Root JC, Schagen SB, McDonald BC, Saykin AJ, Atkinson TM, Li Y, Ahles TA.

Psychooncology. 2016 Jan;25(1):43-50. doi: 10.1002/pon.3799. Epub 2015 Mar 23.

35.

Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, Bruner DW, Cleeland CS, Sloan JA, Chilukuri R, Baumgartner P, Denicoff A, St Germain D, O'Mara AM, Chen A, Kelaghan J, Bennett AV, Sit L, Rogak L, Barz A, Paul DB, Schrag D.

J Natl Cancer Inst. 2014 Sep 29;106(9). pii: dju244. doi: 10.1093/jnci/dju244. Print 2014 Sep.

36.

Pediatric delirium: evaluating the gold standard.

Silver G, Kearney J, Traube C, Atkinson TM, Wyka KE, Walkup J.

Palliat Support Care. 2015 Jun;13(3):513-6. doi: 10.1017/S1478951514000212. Epub 2014 Apr 24.

37.

Patient-reported outcome performance measures in oncology.

Basch E, Snyder C, McNiff K, Brown R, Maddux S, Smith ML, Atkinson TM, Howell D, Chiang A, Wood W, Levitan N, Wu AW, Krzyzanowska M.

J Oncol Pract. 2014 May;10(3):209-11. doi: 10.1200/JOP.2014.001423. Epub 2014 Apr 22. No abstract available.

38.

Cornell Assessment of Pediatric Delirium: a valid, rapid, observational tool for screening delirium in the PICU*.

Traube C, Silver G, Kearney J, Patel A, Atkinson TM, Yoon MJ, Halpert S, Augenstein J, Sickles LE, Li C, Greenwald B.

Crit Care Med. 2014 Mar;42(3):656-63. doi: 10.1097/CCM.0b013e3182a66b76.

39.

Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Hay JL, Atkinson TM, Reeve BB, Mitchell SA, Mendoza TR, Willis G, Minasian LM, Clauser SB, Denicoff A, O'Mara A, Chen A, Bennett AV, Paul DB, Gagne J, Rogak L, Sit L, Viswanath V, Schrag D, Basch E; NCI PRO-CTCAE Study Group.

Qual Life Res. 2014 Feb;23(1):257-69. doi: 10.1007/s11136-013-0470-1. Epub 2013 Jul 20.

40.

Measurement of affective and activity pain interference using the Brief Pain Inventory (BPI): Cancer and Leukemia Group B 70903.

Atkinson TM, Halabi S, Bennett AV, Rogak L, Sit L, Li Y, Kaplan E, Basch E; Cancer and Leukemia Group B.

Pain Med. 2012 Nov;13(11):1417-24. doi: 10.1111/j.1526-4637.2012.01498.x. Epub 2012 Oct 30.

41.

Development and preliminary evaluation of a training workshop for the collection of patient-reported outcome (PRO) interview data by research support staff.

Atkinson TM, Hurley K, Bylund CL, Berk A, Diminni K, Ostroff JS.

J Cancer Educ. 2013 Mar;28(1):33-7. doi: 10.1007/s13187-012-0427-z.

42.

Illness-related distress in women with clinically localized cutaneous melanoma.

Atkinson TM, Noce NS, Hay J, Rafferty BT, Brady MS.

Ann Surg Oncol. 2013 Feb;20(2):675-9. doi: 10.1245/s10434-012-2635-5. Epub 2012 Sep 11.

43.

Reliability of adverse symptom event reporting by clinicians.

Atkinson TM, Li Y, Coffey CW, Sit L, Shaw M, Lavene D, Bennett AV, Fruscione M, Rogak L, Hay J, Gönen M, Schrag D, Basch E.

Qual Life Res. 2012 Sep;21(7):1159-64. doi: 10.1007/s11136-011-0031-4. Epub 2011 Oct 8.

44.

Using versions of the trail making test as alternate forms.

Atkinson TM, Ryan JP, Kryza M, Charette LM.

Clin Neuropsychol. 2011 Oct;25(7):1193-206. doi: 10.1080/13854046.2011.589410. Epub 2011 Jul 25.

PMID:
21780990
45.

Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI).

Atkinson TM, Rosenfeld BD, Sit L, Mendoza TR, Fruscione M, Lavene D, Shaw M, Li Y, Hay J, Cleeland CS, Scher HI, Breitbart WS, Basch E.

J Pain Symptom Manage. 2011 Mar;41(3):558-65. doi: 10.1016/j.jpainsymman.2010.05.008. Epub 2010 Dec 4.

46.

The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations.

Atkinson TM, Mendoza TR, Sit L, Passik S, Scher HI, Cleeland C, Basch E.

Pain Med. 2010 Mar;11(3):337-46. doi: 10.1111/j.1526-4637.2009.00774.x. Epub 2010 Jan 15.

47.

Three trail making tests for use in neuropsychological assessments with brief intertest intervals.

Atkinson TM, Ryan JP, Lent A, Wallis A, Schachter H, Coder R.

J Clin Exp Neuropsychol. 2010 Feb;32(2):151-8. doi: 10.1080/13803390902881934. Epub 2009 May 29.

PMID:
19484644
48.

Patterns of memory: a normative taxonomy of the Wide Range Assessment of Memory and Learning-Second Edition (WRAML-2).

Atkinson TM, Konold TR, Glutting JJ.

J Int Neuropsychol Soc. 2008 Sep;14(5):869-77. doi: 10.1017/S1355617708081137.

49.

Evidence of practice effects in variants of the Trail Making Test during serial assessment.

Buck KK, Atkinson TM, Ryan JP.

J Clin Exp Neuropsychol. 2008 Apr;30(3):312-8. Epub 2007 Sep 11.

PMID:
17852622
50.

Sports-related and gender differences on neuropsychological measures of frontal lobe functioning.

Ryan JP, Atkinson TM, Dunham KT.

Clin J Sport Med. 2004 Jan;14(1):18-24.

PMID:
14712162

Supplemental Content

Loading ...
Support Center